Laboratory of Neurogenomiks
Vall d'Hebron Institut de Recerca
Barcelona, EspañaPublicaciones en colaboración con investigadoras/es de Vall d'Hebron Institut de Recerca (10)
2022
-
Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells
Frontiers in Immunology, Vol. 12
-
Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis
Human Molecular Genetics, Vol. 31, Núm. 13, pp. 2155-2163
2020
-
A new risk variant for multiple sclerosis at 11q23.3 locus is associated with expansion of CXCR5+ circulating regulatory T cells
Journal of Clinical Medicine, Vol. 9, Núm. 3
-
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430
-
The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis
Cells, Vol. 9, Núm. 1
2017
-
Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study
Pharmacogenomics Journal, Vol. 17, Núm. 4, pp. 312-318
2016
-
Analysis of plasminogen genetic variants in multiple sclerosis patients
G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079
-
Novel insights into the multiple sclerosis risk gene ANKRD55
Journal of Immunology, Vol. 196, Núm. 11, pp. 4553-4565
2015
-
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis
Multiple Sclerosis, Vol. 21, Núm. 12, pp. 1498-1512
-
Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e154